DS‐8201a, a new HER2‐targeting antibody–drug conjugate incorporating a novel DNA topoisomerase I inhibitor, overcomes HER2‐positive gastric cancer T‐DM1 resistance
暂无分享,去创建一个
K. Nishio | K. Nakagawa | K. Yonesaka | O. Maenishi | K. Sakai | J. Tsurutani | T. Tamura | N. Takegawa | Y. Nonagase | Y. Ogitani | Yoshikane Nonagase